Antibacterial therapy Flashcards
When drugs are greater than 80% bioavailable, how should you administer them?
Orally….pretty same serum concentration is achieved as IV
When might Vd be increased
When ECFV is increased, as in heart failure
Antimicrobials that do NOT require renal adjustment
Azithromycin Ceftriaxone Clindamycin Cloxacillin Doxycline Linezolid Metronidazole Moxifloxacin
MIC and MBC
MIC= mininum inhibitory concentration is the lowest antimicrobial concentration that inhibits visible growth MBC= minimum bactericidal concentration is the minimum concentration of antimicrobial needed to have bactericidal action
Both are determined with broth dilution. MIC can be determined with Epsilometer testing
Types of antimicrobial susceptibility testing
Disk diffusion (yes/no) Broth dilution (MIC and MBC) E- test (MIC) Synergy testing (synergistic vs. antagonistic effects)
Bacteriostatic drugs are usually…
Bactericidal drugs are usually…
Protein synthesis inhibitors
Cell wall or DNA synthesis inhibitors
When would you use a bactericidal drug
When would you avoid bactericidal drugs
Deep seated infections
vs.
inflammation from bacterial lysis is a danger
Examples of bactericidal drug classes
Beta lactams Carbapenems Fluoroquinilones Aminoglycosides Metroidazole Glycopeptides Lipopeptides
Examples of bacteriostatic drug classes
Macrolides Clindamycin (Lincosamides) Linezolid (Oxazolidinones) Tetracyclines Glycylcyclines Anti-folates
Post antibiotic effect
Continued inhibition of bacterial growth after the antimicrobial is discontinued
Factors in choosing an antimicrobial
Efficacy: susceptibility of organism, infection site
Toxicity: interactions
Patient Factors: renal/hepatic function, weight, allergies, age, pregnancy, immune status
Ease of administration: PO vs. IV, once a day is easier than QID
Cost
Drug classes within beta-lactams
Penicillins
Cephalosporins
Carbapenems
Mechanism of action of beta-lactams and imitations of beta-lactams
- Inhibit cell wall synthesis
- therefore, not active against mycoplasma (they lack a cell wall) and not active vs. intracellular pathogens
Mechanisms of resistance to beta-lactams
- altered penicillin binding protein
- alteration in channel in outer membrane needed to access cell wall (and PBP)
- production of beta-lactamase
PK/PD properties of beta-lactams
- Relatively poor bioavailability (need IV for serious infections)
- Bactericidal
- Wide distribution (incl. bone, and some CNS) with IV
Spectrum of cephalosporins
NO activity vs. enterococci
NO activity vs. MRSA
Carbapenems are usually reserved for…
multi-drug resistance (but not effective vs. MRSA)
Glycopeptides MOA
Inhibit cell wall synthesis earlier than beta-lactams
Lipopeptides MOA
cell wall membrane disruption (unique MOA means less chance of resistance)
Glycopeptide/Lipopeptide spectrum
G+ (including MRSA)
Glycopeptide/Lipopeptide PK/PD
Bactericidal
Poor CSF penetration
Aminoglycoside MOA
Binds to 30S, inhibits protein synthesis
Aminoglycoside PK-PD
Bactericidal
Only IV/IM
Poor CNS and bone penetration
Renal elimination
Macrolides MOA
Protein synthesis inhibtiion (50S)
Macrolides PK/PD
Bacteriostatic
Works agains intracellular organisms
Poor bioavailability
Lincosamides MOA
Protein synthesis inhibition
Lincosamines PK/PD
Bacteriostatic
Excellent bioavailability
Penetrates bone, but not CSF or urine
Tetracyclines and glycylcyclines MOA
Protein synthesis inhibition
Tetracyclines and glycylcyclines PK/PD
Bacteriostatic
Excellent bioavailability
Active vs. intracellular pathogens